Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apellis Pharmaceuticals Inc (NQ: APLS )

47.86 +0.37 (+0.78%)
Streaming Delayed Price Updated: 2:46 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals Inc

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive... 
Via Benzinga
Exposures Product Safety
Apellis-Sobi Partnered Pegcetacoplan Shows Clinically Meaningful Improvements in Rare Blood Disorder Study
Apellis Pharmaceuticals Inc (NASDAQ: APLS) and Swedish Orphan Biovitrum AB (SOBI) have reported positive top-line results from the Phase 3 PRINCE... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 27.99% to $5.99 during Tuesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Drops Over 100 Points; Apellis Pharmaceuticals Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.21% to 34,310.36 while the NASDAQ fell 0.86% to 13,314.36. The S&P also fell, dropping 0.42% to 4,156.26. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021
Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) shares increased by 55.85% to $1.81 during Monday's regular session. The current volume of 136.6 million shares is 10519.... 
Via Benzinga
Mid-Day Market Update: Gold Rises 1.5%; FreightCar America Shares Slide Following Q1 Results
Midway through trading Monday, the Dow traded down 0.54% to 34,194.82 while the NASDAQ fell 0.92% to 13,306.55. The S&P also fell, dropping 0.60% to 4,148.77. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
58 Biggest Movers From Yesterday
Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on... 
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Gainers Nuvve Holding Corp. (NASDAQ: NVVE) shares surged 22.2% to $10.08 after the company announced an agreement with Evolve Transition Infrastructure and Stonepeak to purse a $... 
Via Benzinga
Mid-Morning Market Update: Markets Down; AT&T, Discovery To Merge Media Assets
Following the market opening Monday, the Dow traded down 0.24% to 34,300.61 while the NASDAQ fell 0.48% to 13,366.03. The S&P also fell, dropping 0.23% to 4,164.05. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) shares increased by 20.68% to $1.4 during Monday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
26 Stocks Moving in Monday's Pre-Market Session
Gainers Digital Brands Group, Inc. (NASDAQ: DBGI) shares rose 73.5% to $5.90 in pre-market trading. Digital Brands, on Friday, priced its IPO at $4.15 per share. E-Home Household... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Apellis Stock Is Trading Higher On FDA Approval For Empaveli In Rare Blood Disorder
The FDA has approved Apellis Pharmaceuticals Inc's (NASDAQ: APLS) Empaveli (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal... 
Via Benzinga
Exposures Product Safety
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... 
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021
Upgrades According to Argus Research, the prior rating for United Airlines Holdings Inc (NASDAQ:UAL) was changed from Hold to Buy. In the fourth quarter, United Airlines... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.